Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study

Lisanne M. Baak, Nienke Wagenaar, Niek E. van der Aa, Floris Groenendaal, Jeroen Dudink, Maria Luisa Tataranno, Ubah Mahamuud, Cornelia H. Verhage, Rian M.J.C. Eijsermans, Liesbeth S. Smit, Reint K. Jellema, Timo R. de Haan, Hendrik J. ter Horst, Willem P. de Boode, Sylke J. Steggerda, Henk Jan Prins, Colin G. de Haar, Linda S. de Vries, Frank van Bel, Cobi J. HeijnenCora H. Nijboer, Manon J.N.L. Benders

Research output: Contribution to journal › Article › peer-review

46 Scopus citations

Fingerprint

Dive into the research topics of 'Feasibility and safety of intranasally administered mesenchymal stromal cells after perinatal arterial ischaemic stroke in the Netherlands (PASSIoN): a first-in-human, open-label intervention study'. Together they form a unique fingerprint.

Medicine & Life Sciences